Formulation/Composition Claims and Section 3(d): Analyzing the Utidelone Pre-grant Opposition Order
In light of the recent UTIDELONE patent grant order by the Indian Patent Office, Bharathwaj Ramakrishnan analyses the tactic to present a pharmaceutical invention as a composition to overcome Section 3(d) scrutiny and how this could be bad in law. Bharathwaj is a 3rd year LLB Student at RGSOIPL, IIT Kharagpur, and loves books and IP. His previous posts can be accessed here. Formulation/Composition Claims and Section 3(d): Analyzing the Utidelone Pre-grant Opposition Order By Bharathwaj Ramakrishnan “Name of the game […]









